A comparison of titanium clips versus Roeder's knot tying suture in laparoscopic appendiceal stump closure: A 1-year randomized controlled trial study in KLES Dr. Prabhakar Kore Charitable Hospital, Belgaum

Background and Objectives: Appendiceal stump closure during laparoscopic appendectomy (LA) is an important step. This study was an attempt to evaluate the ease of use and safety of titanium clips compared to Roeder's knot in the appendiceal stump closure in patients undergoing LA by comparing complications (intraoperative and postoperative), hospital stay, and follow-up period. Materials and Methods: This 1-year randomized controlled trial was done in under the Department of General Surgery, KLES Dr. Prabhakar Kore Hospital and Medical Research Centre, Belgaum from January 2014 to December 2014. A total of 60 patients were divided into two groups of 30 each that is, Group R (Roeder's knot using silk suture and Group T (titanium clips). Results: In this study 53.33% of the patients in Group R were females as compared to 36.67% in Group T (P = 0.795). The mean age in Group R was 29.77 ± 11.24 years and in Group T, it was 29.53 ± 8.96 (P = 0.929). Other preoperative characteristics of the study population in Group R and T were comparable (P > 0.050). Significantly higher number of patients (60%) in Group T required lower operative time (45–60 min) compared to Group R (83.33% patients required 61–75 minP 0.050). Conclusion and Interpretation: Appendiceal stump closure with titanium clips is advantageous in terms of operative time, pressure gradient, and offers early resumption of daily activities

Clinical study of add on effect of Triphaladaruadi Kwatha (Vangsenokta) along with antidiabetic drug in management of Prameha (Non-Insulin Dependent Diabetes mellitus- NIDDM)

Prameha (Diabetes mellitus) is an age long disease known from vedic period and now it is a leading lifestyle disorder. Diabetes mellitus is a group of metabolic syndromes of fat, protein and carbohydrate which is due to absolute or relative deficiency of insulin. The prevalence of diabetes in India has risen from 7.1% in 2009 to 8.9% in 2019.1 The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over 134 million by 2045.2 In India, it is also 3rd leading cause of death (After heart disease and cancer). The number is projected to be twice by 2030. Type 2 diabetes makes up about 85-90% of all cases. Increase in the overall diabetes prevalence rates largely reflect an increase in risk factors for type 2, notably greater longevity and being overweight or obese. Hence preventive measures are essential and an ideal therapy is still obscure. It remains one of the baffling enigmas for clinical research. This is a randomized single blind standard controlled clinical trial conducted on 66 patients of Prameha (Type II DM & who are on antidiabetic treatment) to rule out Add on effect of Triphaladaruadi kwath of either gender between age group of 40-60 years and grouped into Group A & Group B. 33 patients in group A were on Antidiabetic drug (Metformin 500mg OD/BD and 33 patients in Group B are on same antidiabetic drug (Metformin 500mg OD/BD) with additional Triphaladaruadi kwath (Decoction) for 3 months. Results obtained in subjective and objective parameters were analyzed for the statistical significance by adapting paired ‘t’ test in the groups, Two-way ANOVA test between the groups, and Wilcoxon rank sum test. The study revealed that Group B was found to be more effective in bringing symptomatic relief and improving biochemical markers in the patients of Prameha